Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know: – MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that…
Digital health tech creating ‘connective tissue’ to link care settings, clinicians, and evidence
Beyond virtual care, digital health tech companies are building solutions designed to improve efficiency and outcomes. Maintaining connectivity and consistency for patients and providers becomes essential in a more systems-focused…